Bone mineral loss in HIV-positive patients receiving antiretroviral therapy

被引:8
作者
Weiel, JE [1 ]
Lenhard, JM [1 ]
机构
[1] Glaxo Wellcome Inc, Dept Metab Dis, Res Triangle Pk, NC 27709 USA
关键词
D O I
10.1097/00002030-200009290-00028
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
引用
收藏
页码:2218 / 2219
页数:2
相关论文
共 4 条
[1]  
MALLAL S, 1999, ANTIVIR THER S, V4, P42
[2]  
PERLARD JM, 1999, BIOCHEM PHARMACOL, V100, P700
[3]   A syndrome of peripheral fat wasting (lipodystrophy) in patients receiving long-term nucleoside analogue therapy [J].
Saint-Marc, T ;
Partisani, M ;
Poizot-Martin, I ;
Bruno, F ;
Rouviere, O ;
Lang, JM ;
Gastaut, JA ;
Touraine, JL .
AIDS, 1999, 13 (13) :1659-1667
[4]   Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy [J].
Tebas, P ;
Powderly, WG ;
Claxton, S ;
Marin, D ;
Tantisiriwat, W ;
Teitelbaum, SL ;
Yarasheski, KE .
AIDS, 2000, 14 (04) :F63-F67